pillbase.ru

ZINPLAVA

Active substance: bezlotoxumab

INJECTION, SOLUTION · BEZLOTOXUMAB 25 mg/mL

United StatesActive

Marketing holder: Merck Sharp & Dohme LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Зинплава
    концентрат для приготовления раствора для инфузий, 25 мг/мл, 40 мл (original in Russian, GRLS)
    ЛП-006872
    ООО "МСД Фармасьютикалс"
EU 1
  • Zinplava
    Bezlotoxumab
    EMEA/H/C/004136
    Merck Sharp & Dohme B.V.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c4-ba7b-7691-9943-f2e2d304ed18;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1209d-243c-725d-bc02-956ef2cb37c3;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0006-3025
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 0006-3025 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0006-3025 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0006-3025 · Verified 2026-10-09 · open in source